Lawson scientists Drs. Tamara Spaic (left) and Cheril Clarson (centre) have developed a structured transition program that provides additional support to young adults moving from paediatric to adult care. Nicole (right) was one of the patients who participated in the study.
When young adults with type 1 diabetes move from paediatric to adult care they often drop out of medical care and their diabetic control deteriorates. This can lead to increased diabetes-related hospital admissions and acceleration of diabetic complications. Lawson Health Research Institute scientists Drs. Tamara Spaic and Cheril Clarson have developed a structured transition program that has been shown to improve care during this high-risk period.
Dr. Stephen Welch (left) is the principal investigator and Dr. Bekim Sadikovic (right) is the laboratory lead for the London site of the OCTANE trial.
Understanding a cancer’s genetics is key to selecting targeted therapies that are likely to be of the most benefit to a patient. The Ontario Institute for Cancer Research (OICR) has announced a new study, called Ontario-wide Cancer TArgeted Nucleic Acid Evaluation (OCTANE).